An approach combining extensive genomic analysis and drug sensitivity profiling of TCF::HLF-positive ALL led to a demonstration of an exquisite sensitivity of TCF3::HLF-positive ALL to venetoclax and the conclusion that this could be a relevant druggable dependency [28]. This evidence concerns the gene TCF3 and acute lymphoblastic leukemia.